Comparative Effectiveness of the Different Treatment Modalities for Management of Vaso-occlusive Painful Crisis in Pediatric Sickle Cell Disease
3 Egypt sites
1 Saudi Arabia site
5 to 15 Years
Phase 2/Phase 3
About the study
The aim of the present study is comparing the effectiveness of different treatment regimens
for investigating the therapeutic potential for each one in management of Vaso-occlusive pain
in pediatric sickle cell disease. In addition, investigators apply the Cost-effectiveness
analysis (CEA) as a form of economic analysis that compares the relative costs and outcomes
(effects) for different treatment regimens on vaso-occlusive painful crisis.
Any case with the full manifestation of sickle cell disease accompanied by acute painful
crisis aged from 5-15 years old.
1. The presence of any other chronic illness.
2. Patient age>18 years old or < 3 years old.
3. Patients with hepatic diseases including cholestasis hepatic encephalopathy and
4. Patients with renal impairment
5. Diabetic patients
Banī Suwayf, Egypt, Faculty of medicine, Beni-suef univeristy - Beni-Seuf university hospital
Banī Suwayf, Egypt, Faculty of Pharmacy, Beni-Suef university
Banī Suwayf, Egypt, Health insurance hospital
Mecca, Saudi Arabia, Maternity and Children hospital